IP Library Granted Patent US 10,533,200
Granted Patent B2
US 10,533,200 · App. 16/007,523 · Granted Jan 14, 2020

Method for the production of fine chemicals using a

Inventors: Kornelia Voss (Halle, DE); Michaela Voss (Steinhagen, DE); Georg Thierbach (Bielefeld, DE)
Assignee: Evonik Degussa GmbH
C12P13/06C12N1/20C12N9/2451C12N15/77C12P13/04C12P13/08C12P19/02C12P19/14C12P19/30C12P19/38C12P25/00C12Y302/0101C07K2319/10C12Y302/01033
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,533,200
App. No.
16/007,523
Granted
Jan 14, 2020
Kind
B2
Abstract

The present invention relates to polynucleotides encoding novel fusion polypeptides essentially composed of a signal peptide for membrane translocation and a polypeptide providing α-1,6-glucosidase activity and to bacteria containing said polynucleotides. The invention further relates to methods for producing fine chemicals using media containing isomaltose and/or panose as carbon source.

Claims (26)

1. An isolated polynucleotide encoding a fusion polypeptide comprising the amino acid sequences a), b) and c) wherein:

a) is an N-terminal Tat-signal peptide comprising the amino acid sequence of positions 1 to 33 of SEQ ID NO:10 or positions 1 to 33 of SEQ ID NO:12 or

 comprising the amino acid sequence of positions 1 to 33 of SEQ ID NO:10 with Ala at position 13 or positions 1 to 33 of SEQ ID NO:12 with Ala at position 13;

b) is a C-terminal polypeptide having α-1,6-glucosidase activity comprising an amino acid sequence selected from the group consisting of:

b1) a sequence ≥95% identical to the sequence from positions 37 to 639 of SEQ ID NO:10; and

b2) at least (≥) 95% identical to the sequence from positions 37 to 643 of SEQ ID NO:12, and

c) is 0 to 10 amino acid residues between a) and b).

2. The isolated polynucleotide of claim 1 , wherein:

a) the amino acid sequence of b1) is selected from: positions 37 to 639 of SEQ ID NO:10; and from positions 37 to 639 of SEQ ID NO:10 plus an additional Met at the N-terminus in front of position 37 as shown in SEQ ID NO:6; and

b) the sequence of b2) is selected from: positions 39 to 643 of SEQ ID NO:12; positions 38 to 643 of SEQ ID NO:12; and positions 37 to 643 of SEQ ID NO:12.

3. The isolated polynucleotide of claim 1 , wherein the number of amino acid residues of c) is 1 to 3.

4. The isolated polynucleotide of claim 3 , wherein the number of amino acid residues of c) is 3.

5. The isolated polynucleotide of claim 4 , wherein the amino acid residues between a) and b) consist of the amino acid sequence Met Thr Ser.

6. The isolated polynucleotide of claim 4 , wherein the amino acid residues of c) consist of the amino acid sequence Ile Leu Val.

7. The isolated polynucleotide of claim 1 , wherein said polynucleotide is functionally linked to a promotor.

8. The isolated polynucleotide of claim 7 , wherein said promotor is the PtacI promotor comprising the nucleotide sequence of SEQ ID NO:14 from positions 1 to 75 or the PdapBN1 promotor comprising the nucleotide sequence of SEQ ID NO:15.

9. The isolated polynucleotide of claim 8 , wherein said promotor is the PdapBN1-promotor comprising the sequence of SEQ ID NO:15.

10. A bacterium selected from the genus Corynebacterium and comprising the isolated polynucleotide of claim 1 , wherein said bacterium has the ability to secrete a polypeptide having α-1,6-glucosidase activity encoded by said isolated polynucleotide.

11. The bacterium of claim 10 , wherein said isolated polynucleotide is contained in a plasmid vector autonomously replicating in said bacterium or in the chromosome of said bacterium.

12. The bacterium of claim 10 , wherein said bacterium is a Corynebacterium glutamicum.

13. The bacterium of claim 10 , wherein said bacterium has the ability to excrete and produce a fine chemical selected from the group consisting of: L-amino acids; vitamins; nucleosides; and nucleotides.

14. The bacterium of claim 13 , wherein said fine chemical is an L-amino acid.

15. The bacterium of claim 14 , wherein said L-amino acid is selected from the group consisting of: L-lysine; L-threonine; L-valine; and L-isoleucine.

16. A method for producing a fine chemical selected from the group consisting of: L-amino acids; vitamins; nucleosides; and nucleotides; said method comprising culturing the fine chemical producing bacterium according to claim 10 in a suitable medium, where said medium comprises oligomers of a-D-glucose consisting of least two alpha-1-6-glycosidically linked glucose monomers as carbon source.

17. The method of claim 16 , wherein said fine chemical is an L-amino acid.

18. The method of claim 17 , wherein said L-amino acid is selected from the group consisting of: L-lysine; L-threonine; L-valine; and L-isoleucine.

Assignments (3)
CHANGE OF NAME Recorded Dec 12, 2019
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051271/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2019
From: VOSS, KORNELIA; VOSS, MICHAELA; THIERBACH, GEORG
To: EVONIK DEGUSSA GMBH
Reel/Frame 049120/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2018
From: VOSS, KORNELIA; VOSS, MICHAELA; THIERBACH, GEORG
To: EVONIK DEGUSSA GMBH
Reel/Frame 047246/0946 →
Priority Claims (1)
EP 17175992 · Jun 14, 2017 · regional
Continuity (1)
Related Publication 20180363014A1 · Dec 20, 2018